ACTIVE-6

Study / ResearchMentioned in 1 video

A randomized trial of Ivermectin for COVID-19 treatment, funded by NIH and NIAID, with results expected in March 2023.

Videos Mentioning ACTIVE-6

Jay Bhattacharya: The Case Against Lockdowns | Lex Fridman Podcast #254

Jay Bhattacharya: The Case Against Lockdowns | Lex Fridman Podcast #254

Lex Fridman

A randomized trial of Ivermectin for COVID-19 treatment, funded by NIH and NIAID, with results expected in March 2023.